SUBSCRIBE: eNewsletter
In new research published in the New England Journal of Medicine, investigators led by William Tamborlane, M.D., a Yale University pediatric endocrinologist, reported the efficacy of the GLP1 agonist liraglutide for children with type 2 diabetes. In this Q&A, Dr. Tamborlane discusses the importance of expanding treatment options.
Stimulating the sphenopalatine ganglion—a collection of nerve cells closely associated with the trigeminal nerve most responsible for headaches—could be a safe intervention for patients with acute ischemic stroke who aren’t eligible for thrombolytic therapy, researchers report in The Lancet.
Awareness of the prevalence of hypertension has increased substantially over the past 40 years in high-income countries, as has treatment and control of the condition. But, the level of control falls short of rates seen in dedicated hypertension programs, and it’s stagnating, according to research published last month in The Lancet.
Stimulating the sphenopalatine ganglion—a collection of nerve cells closely associated with the trigeminal nerve most responsible for headaches—could be a safe intervention for patients with acute ischemic stroke who aren’t eligible for thrombolytic therapy, according to an article published in The Lancet last month.
Women who have primary Sjögren’s Syndrome also have decreased lifetime exposure to estrogen, a new study has determined.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
